You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pamiparib

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Hefei (Pamiparib, Surufatinib)

Recruiting
  • Ovarian Cancer
  • Hefei, Anhui, China
    Anhui Cancer Hospital
Dec 6, 2022

Epithelial Ovarian Cancer Trial in Hangzhou (Pamiparib)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pamiparib
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Aug 4, 2022

Ovarian Cancer, Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial (Pamiparib, Surufatinib)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Aug 8, 2022

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

Recruiting
  • Neoadjuvant Therapy
  • pamiparib
  • +2 more
  • Nanjing, Jiangsu, China
  • +2 more
Jan 3, 2023

Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)

Recruiting
  • Limited Stage Small Cell Lung Cancer
  • Pamiparib
  • Shanghai, Shanghai, China
  • +1 more
Jul 29, 2022

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)

Recruiting
  • Glioblastoma
  • +2 more
  • Pamiparib
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
May 3, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Pamiparib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 7, 2022

Cancer Trial in Melbourne (Pamiparib, Tislelizumab)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Mar 3, 2022

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Ovarian Cancer, Carcinosarcoma Trial (Pamiparib)

Withdrawn
  • Ovarian Cancer
  • Carcinosarcoma
  • Pamiparib
  • (no location specified)
Aug 3, 2021

Metastatic Castration-Resistant Prostate Cancer (mCRPC), Homologous Recombination Deficiency (HRD) Trial in Worldwide

Terminated
Has Results
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Homologous Recombination Deficiency (HRD)
  • Pamiparib
  • Athens, Georgia
  • +8 more
Oct 20, 2021

Ovarian Cancer Trial in Wuhan (Pamiparib, Bevacizumab, Tislelizumab)

Not yet recruiting
  • Ovarian Cancer
  • Pamiparib
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Oct 6, 2021

Advanced High-grade Ovarian Cancer, Triple Negative Breast Cancer Trial in China (Pamiparib)

Active, not recruiting
  • Advanced High-grade Ovarian Cancer
  • Triple Negative Breast Cancer
  • Pamiparib
  • Hefei, Anhui, China
  • +25 more
Jun 16, 2021

Solid Tumors Trial in Worldwide (Tislelizumab, Pamiparib)

Completed
Has Results
  • Solid Tumors
  • Tislelizumab
  • Pamiparib
  • Scottsdale, Arizona
  • +28 more
Oct 27, 2021

Advanced or Inoperable Gastric Cancer Trial in Worldwide (pamiparib, Placebo)

Completed
  • Advanced or Inoperable Gastric Cancer
  • pamiparib
  • Placebo
  • Santa Rosa, California
  • +140 more
Jan 10, 2023